|

CTX-10726 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Compass Therapeutics1

Indications

  • Liver Disease1
  • Gastroesophageal Cancer (GC)1
  • Renal Cell Carcinoma (RCC)1
  • Hepatocellular Carcinoma (HCC)1
  • Endometrial Cancer1

Omaha, Nebraska1 trial

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Nebraska Cancer Specialists

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.